These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 9804241)

  • 1. Soluble adhesion molecules in serum and cyst fluid from patients with cystic tumours of the ovary.
    Daraï E; Bringuier AF; Walker-Combrouze F; Feldmann G; Madelenat P; Scoazec JY
    Hum Reprod; 1998 Oct; 13(1O):2831-5. PubMed ID: 9804241
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Higher levels of soluble E-cadherin in cyst fluid from malignant ovarian tumours than in benign cysts.
    Sundfeldt K; Ivarsson K; Rask K; Haeger M; Hedin L; Brännström M
    Anticancer Res; 2001; 21(1A):65-70. PubMed ID: 11299791
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of cadherins and CD44 isoforms in ovarian endometrial cysts.
    Daraï E; Leblanc M; Walker-Combrouze F; Bringuier AF; Madelenat P; Scoazec JY
    Hum Reprod; 1998 May; 13(5):1346-52. PubMed ID: 9647570
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vascular endothelial growth factor levels in ovarian cyst fluid correlate with malignancy.
    Hazelton D; Nicosia RF; Nicosia SV
    Clin Cancer Res; 1999 Apr; 5(4):823-9. PubMed ID: 10213218
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gonadotropin (LH, FSH) levels in serum and cyst fluid in epithelial tumors of the ovary.
    Chudecka-Głaz A; Rzepka-Górska I; Kosmowska B
    Arch Gynecol Obstet; 2004 Nov; 270(3):151-6. PubMed ID: 12883823
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Concentrations of follicle stimulating hormone are increased in ovarian tumor fluid: implications for the management of ovarian cancer.
    Chudecka-Głaz A; Rzepka-Górska I
    Eur J Gynaecol Oncol; 2008; 29(1):37-42. PubMed ID: 18386461
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CA 125 and vascular endothelial growth factor in the differential diagnosis of epithelial ovarian tumors.
    Candido Dos Reis F; Moreira de Andrade J; Bighetti S
    Gynecol Obstet Invest; 2002; 54(3):132-6. PubMed ID: 12571433
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vascular endothelial growth factor in adnexal masses.
    Demirkiran F; Kumbak B; Bese T; Arvas M; Benian A; Aydin S; Uzun H; Sanioglu C; Aydinli K; Kösebay D
    Int J Gynaecol Obstet; 2003 Oct; 83(1):53-8. PubMed ID: 14511872
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cell adhesion molecules in bladder cancer: soluble serum E-cadherin correlates with predictors of recurrence.
    Griffiths TR; Brotherick I; Bishop RI; White MD; McKenna DM; Horne CH; Shenton BK; Neal DE; Mellon JK
    Br J Cancer; 1996 Aug; 74(4):579-84. PubMed ID: 8761373
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Soluble adhesion molecules E-cadherin, intercellular adhesion molecule-1, and E-selectin as lung cancer biomarkers.
    Gogali A; Charalabopoulos K; Zampira I; Konstantinidis AK; Tachmazoglou F; Daskalopoulos G; Constantopoulos SH; Dalavanga Y
    Chest; 2010 Nov; 138(5):1173-9. PubMed ID: 20495107
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vascular endothelial growth factor and its soluble receptor in benign and malignant ovarian tumors.
    Artini PG; Ruggiero M; Monteleone P; Carpi A; Cristello F; Cela V; Genazzani AR
    Biomed Pharmacother; 2008; 62(6):373-7. PubMed ID: 18037256
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Placental protein 12 (PP 12) in cyst and peritoneal fluids and serum samples of patients with ovarian cysts and cystic ovarian tumors].
    Strache RR; Göcze PM; Szábo DG; Büttner HH; Briese V; Kunze M; Csaba IF; Röpcke G
    Zentralbl Gynakol; 1989; 111(11):749-54. PubMed ID: 2781888
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Early inflammatory response in epithelial ovarian tumor cyst fluids.
    Kristjánsdóttir B; Partheen K; Fung ET; Yip C; Levan K; Sundfeldt K
    Cancer Med; 2014 Oct; 3(5):1302-12. PubMed ID: 24947406
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Calgranulins in cystic fluid and serum from patients with ovarian carcinomas.
    Ott HW; Lindner H; Sarg B; Mueller-Holzner E; Abendstein B; Bergant A; Fessler S; Schwaerzler P; Zeimet A; Marth C; Illmensee K
    Cancer Res; 2003 Nov; 63(21):7507-14. PubMed ID: 14612552
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Apolipoprotein concentrations are elevated in malignant ovarian cyst fluids suggesting that lipoprotein metabolism is dysregulated in epithelial ovarian cancer.
    Podzielinski I; Saunders BA; Kimbler KD; Branscum AJ; Fung ET; DePriest PD; van Nagell JR; Ueland FR; Baron AT
    Cancer Invest; 2013 May; 31(4):258-72. PubMed ID: 23627408
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The value of cyst puncture in the differential diagnosis of benign ovarian tumours.
    Vercellini P; Oldani S; Felicetta I; Bramante T; Rognoni MT; Crosignani PG
    Hum Reprod; 1995 Jun; 10(6):1465-9. PubMed ID: 7593516
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Assessment of soluble intracellular adhesion molecule-1 (sICAM-1) in women with benign ovarian tumors].
    Rzymski P; Opala T; Woźniak J; Drews K; Sajdak S
    Ginekol Pol; 2004 Oct; 75(10):785-92. PubMed ID: 15587910
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased concentrations of neopterin in plasma, ascites and ovarian cyst fluid in malignant tumours compared with benign ovarian tumours.
    Haeger M; Swahn M; Hahlin M; Horvath G; Bengtsson A
    Anticancer Res; 1996; 16(5B):3189-92. PubMed ID: 8967734
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical value of components of the plasminogen activation system in ovarian cyst fluid.
    Boss EA; Massuger LF; Thomas CM; Geurts-Moespot A; van Schaik JH; Boonstra H; Sweep CG
    Anticancer Res; 2002; 22(1A):275-82. PubMed ID: 12017303
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Soluble receptor for urokinase plasminogen activator in both full-length and a cleaved form is present in high concentration in cystic fluid from ovarian cancer.
    Wahlberg K; Høyer-Hansen G; Casslén B
    Cancer Res; 1998 Aug; 58(15):3294-8. PubMed ID: 9699658
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.